Summit Surgical, Llc | |
1818 East 23rd Avenue, Hutchinson, Kansas 67502 | |
(620) 662-6000 | |
Not Available |
Name | Summit Surgical, Llc |
---|---|
Type | Acute Care Hospital |
Location | 1818 East 23rd Avenue, Hutchinson, Kansas |
Ownership | Physician |
Emergency Services | No |
Medicare ID (CCN) | 170198 |
NPI Number | 1770095010 |
Organization Name | HUTCHINSON REGIONAL MEDICAL CENTER, INC. |
Address | 1818 E 23rd Ave, Hutchinson, KS 67502 |
Hospital Type | General Acute Care Hospital |
Phone Number | 620-663-4800 |
News Archive
An international team of scientists have observed a previously unclear inflammatory mechanism caused by airborne particles that can worsen asthma symptoms, it has been reported in Toxicological Sciences.
This is the strangest P.R. campaign yet against the Affordable Care Act. Generation Opportunity, the Koch-funded group behind the Creepy Uncle Sam ads, is throwing tailgate parties to "educate" young people about the exchanges. Read: To convince young people to forgo health insurance.
Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.
Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.
› Verified 3 days ago
NPI Number | 1932117975 |
Organization Name | SUMMIT SURGICAL LLC |
Address | 1818 E 23rd Ave, Hutchinson, KS 67502 |
Hospital Type | Special Hospital |
Phone Number | 620-663-4800 |
News Archive
An international team of scientists have observed a previously unclear inflammatory mechanism caused by airborne particles that can worsen asthma symptoms, it has been reported in Toxicological Sciences.
This is the strangest P.R. campaign yet against the Affordable Care Act. Generation Opportunity, the Koch-funded group behind the Creepy Uncle Sam ads, is throwing tailgate parties to "educate" young people about the exchanges. Read: To convince young people to forgo health insurance.
Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.
Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.
› Verified 3 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | No |
News Archive
An international team of scientists have observed a previously unclear inflammatory mechanism caused by airborne particles that can worsen asthma symptoms, it has been reported in Toxicological Sciences.
This is the strangest P.R. campaign yet against the Affordable Care Act. Generation Opportunity, the Koch-funded group behind the Creepy Uncle Sam ads, is throwing tailgate parties to "educate" young people about the exchanges. Read: To convince young people to forgo health insurance.
Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.
Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.
› Verified 3 days ago
Hutchinson Regional Medical Center Inc Acute Care Hospital Location: 1701 E 23rd Avenue, Hutchinson, Kansas 67502 Phone: (620) 665-2001 | |
Summit Surgical, Llc Acute Care Hospital Location: 1818 East 23rd Avenue, Hutchinson, Kansas 67502 Phone: (620) 662-6000 |